Vaxart, Inc.
VXRT· OTC
Filed May 10, 2013 · 10-Q · 40 days after period end · 0001437749-13-005823
| Metric | Q3 2013 | Q3 2011 | Q3 2010 |
|---|---|---|---|
| Revenue | $12.50M | $1.09M | $12.34M |
| Net Income | $200.00K | $78.00K | $5.14M |
| EPS Diluted | $0.01 | -$0.07 | $0.12 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Vaxart, Inc. · CIK 72444 · Engraved from SEC EDGAR
ended Mar 31, 2013 · filed May 10, 2013 · 40 d after period end